Effects of the CYP2D6 genotype on the steady-state plasma concentrations of haloperidol and reduced haloperidol in Japanese schizophrenic patients

被引：61
|
作者：
Suzuki, A
Otani, K
Mihara, K
Yasui, N
Kaneko, S
Inoue, Y
Hayashi, K
机构：
[1] YAMAGATA UNIV,SCH MED,DEPT NEUROPSYCHIAT,YAMAGATA 99023,JAPAN
[2] YOSHITOMI PHARMACEUT IND LTD,CTR PHARMACEUT TECHNOL,FUKUOKA 871,JAPAN
[3] GUNMA UNIV,SCH HLTH SCI,DEPT ALLIED MED SCI,MAEBASHI,GUMMA 371,JAPAN
来源：
PHARMACOGENETICS | 1997年 / 7卷 / 05期
关键词：
CYP2D6; genotype; haloperidol; reduced haloperidol; steady-state plasma concentration;
D O I：
10.1097/00008571-199710000-00013
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：415 / 418
页数：4
相关论文
共 50 条
  • [31] In vitro study on the involvement of CYP1A2, CYP2D6 and CYP3A4 in the metabolism of haloperidol and reduced haloperidol
    L. Pan
    F. M. Belpaire
    European Journal of Clinical Pharmacology, 1999, 55 : 599 - 604
  • [32] Histamine H1-receptor antagonists, promethazine and homochlorcyclizine, increase the steady-state plasma concentrations of haloperidol and reduced haloperidol
    Suzuki, A
    Yasui-Furukori, N
    Mihara, K
    Kondo, T
    Furukori, H
    Inoue, Y
    Kaneko, S
    Otani, K
    THERAPEUTIC DRUG MONITORING, 2003, 25 (02) : 192 - 196
  • [33] Effect of CYP2D6 genotypes on the metabolism of haloperidol in a Japanese psychiatric population
    Someya, T
    Shimoda, K
    Suzuki, Y
    Sato, S
    Kawashima, Y
    Hirokane, G
    Morita, S
    Yokono, A
    Takahashi, S
    NEUROPSYCHOPHARMACOLOGY, 2003, 28 (08) : 1501 - 1505
  • [34] Effect of CYP2D6 Genotypes on the Metabolism of Haloperidol in a Japanese Psychiatric Population
    Toshiyuki Someya
    Kazutaka Shimoda
    Yutaro Suzuki
    Satoshi Sato
    Yoshiaki Kawashima
    Genta Hirokane
    Sachiyo Morita
    Aya Yokono
    Saburo Takahashi
    Neuropsychopharmacology, 2003, 28 : 1501 - 1505
  • [35] Impact of CYP2D6 on serum concentrations of flupentixol, haloperidol, perphenazine and zuclopenthixol
    Waade, Ragnhild Birkeland
    Solhaug, Vigdis
    Hoiseth, Gudrun
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 87 (05) : 2228 - 2235
  • [36] Effects of itraconazole on the steady-state plasma concentrations of bromperidol and reduced bromperidol in schizophrenic patients
    Furukori, H
    Kondo, T
    Yasui, N
    Otani, K
    Tokinaga, N
    Nagashima, U
    Kaneko, S
    Inoue, Y
    PSYCHOPHARMACOLOGY, 1999, 145 (02) : 189 - 192
  • [37] Effects of various CYP2D6 genotypes on the steady-state plasma concentrations of risperidone and its active metabolite, 9-hydroxyrisperidone, in Japanese patients with schizophrenia
    Mihara, K
    Kondo, T
    Yasui-Furukori, N
    Suzuki, A
    Ishida, M
    Ono, S
    Kubota, T
    Iga, T
    Takarada, Y
    de Vries, R
    Kaneko, S
    THERAPEUTIC DRUG MONITORING, 2003, 25 (03) : 287 - 293
  • [38] Effects of itraconazole on the steady-state plasma concentrations of bromperidol and reduced bromperidol in schizophrenic patients
    Hanako Furukori
    T. Kondo
    Norio Yasui
    Koichi Otani
    Noboru Tokinaga
    Udai Nagashima
    Sunao Kaneko
    Yoshimasa Inoue
    Psychopharmacology, 1999, 145 : 189 - 192
  • [39] Significant dose effect of carbamazepine on reduction of steady-state plasma concentration of haloperidol in schizophrenic patients
    Yasui-Furukori, N
    Kondo, T
    Mihara, K
    Suzuki, A
    Inoue, Y
    Kaneko, S
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2003, 23 (05) : 435 - 440
  • [40] Lack of correlation between the steady-state plasma concentrations of haloperidol and risperidone
    Yasui-Furukori, N
    Kondo, T
    Mihara, K
    Suzuki, A
    Inoue, Y
    De Vries, R
    Kaneko, S
    JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 42 (10): : 1083 - 1088
12345